EVENT SUMMARY
The AJMC® annual Patient-Centered Oncology Care® (PCOC) conference connects leaders across oncology and value-based care, allowing them to share insights into the rapidly changing cancer care landscape. Our theme, Finding Our Rhythm: Embracing Change in Oncology Care, was addressed in our first panel discussion, In a Wave of Change: Advocacy Is Everyone’s Job, which highlighted the need for oncology professionals at all levels to engage with policymakers.

PCOC Cochair Davey Daniel, MD, of OneOncology led discussions on day one, while Cochair Kathy Oubre, MS, of Pontchartrain Cancer Center testified in Washington, DC; she joined the conference for the second day’s sessions.

For the second year, leaders from cancer care networks and managed service organizations—The US Oncology Network, OneOncology, American Oncology Network, and ONCare Alliance—presented different models for sharing ideas and resources at scale. In addition to popular panels on precision medicine, clinical pathways, and payer perspectives, PCOC 2025 offered new discussions on survivorship and the relationship between primary and oncology care. To learn more, look for our annual PCOC recap issue, which will be published in December 2025.

Technology and AI Are Making Waves

Throughout the conference, experts shared how advances in artificial intelligence (AI), decision support tools, and predictive analytics are helping clinicians reach the right decisions in less time.

But Clinicians Are Still Learning When AI Is Appropriate

Using AI to find clinical trials for patients is very different than using it for clinical pathways—it’s the difference between using AI for what you could do vs what you must do, said David Jackman, MD, of Dana-Farber Cancer Institute.

Handoffs Count Between Primary Care and Oncology

Time and resources should be spent on support staff and navigators who guide patients from a positive screening for cancer to the first visit to an oncologist.

Consolidation Is Driving Care Into Hospitals

Vertical integration is making it harder for independent community oncology practices to compete. As more oncology practices fold into hospital systems, costs will continue to rise, said Sucharu “Chris” Prakash, MD, of Texas Oncology.

Advocacy Can Lead to Access

Leaders from OneOncology shared how joining forces across the organization aided the Center for Cancer and Blood Disorders in its pursuit of a Texas law that will require coverage for CAR T-cell therapy. Said Lisa Sowinski-Raff, PharmD, BCPS, BCOP: “Therapies aren’t innovative unless they can get to patients.”

Everything, Everywhere, All at Once

PCOC concluded with a panel of leaders from the world of pharmaceutical manufacturing. Moderated by Ryan Haumschild, PharmD, MS, MBA, CPEL, the group referenced the news coming from Washington, DC, and elsewhere that could greatly affect the future of the industry. Panelists said there is not one single policy that has the pharma industry concerned; the greater worry is constant upheaval and how policies will interact with each other.

PCOC 2025 BY THE NUMBERS
The following titles were accurate as of the PCOC 2025 event but may have changed since then.
81
Faculty
44
Institutions Represented Among Faculty
15
Multidisciplinary Panel Discussions
35
Articles & Videos Produced by AJMC®
Lalan S. Wilfong, MD
Lalan S. Wilfong, MD

Senior Vice President, Value Based Care, Thyme Care

Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC
Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC

Vice President of Clinical Innovation, American Oncology Network

Matthew Zachary
Matthew Zachary

Founder, Stupid Cancer

Judith Alberto, RPh, BCOP, MHA
Judith Alberto, RPh, BCOP, MHA

Director of Clinical Initiatives, Community Oncology Alliance

Grant Andres, BSc, DC, BSN, MSN-RN, CLSSBB, CPHQ
Grant Andres, BSc, DC, BSN, MSN-RN, CLSSBB, CPHQ

Senior Director, Clinical Operations, Arizona Oncology

Edward R. ``Ted`` Arrowsmith, MD, MPH
Edward R. ``Ted`` Arrowsmith, MD, MPH

Executive Vice President of Quality and Clinical Operations, Physician Services, and Therapeutics, Tennessee Oncology

Derek Asay
Derek Asay

Senior Vice President, Government Strategy and Federal Accounts, Lilly USA

Amy J. Barton, MHA
Amy J. Barton, MHA

Regional Director, Managed Care, The US Oncology Network

Nicholas Capote, PharmD, MS, BCSCP
Nicholas Capote, PharmD, MS, BCSCP

Pharmacy Director, Oncology, Infusion, and Investigational Drug Pharmacy Services, UCSF Health

Sophia Humphreys, PharmD, MHA, BCBBS
Sophia Humphreys, PharmD, MHA, BCBBS

Director, System Pharmacy Formulary Management & Clinical Programs, Sutter Health

Sarah Hogue, PharmD
Sarah Hogue, PharmD

Director, Oncology Pharmacy Services, St. Luke's Cancer Institute

Ryan Haumschild, PharmD, MS, MBA, CPEL
Ryan Haumschild, PharmD, MS, MBA, CPEL

Vice President of Ambulatory Pharmacy, Emory Healthcare and the Winship Cancer Institute

Alexandra Hacker
Alexandra Hacker

Director of Quality Programs & Health Outcomes, Williamette Valley Cancer Institute and Research Center

Gustavo Fonseca, MD, FACP
Gustavo Fonseca, MD, FACP

Physician Director of Clinical Research, Florida Cancer Specialists & Research Institute

Mark Fendrick, MD
Mark Fendrick, MD

Director, Center for Value-Based Insurance Design, University of Michigan

Chris Elder, PharmD, BCOP
Chris Elder, PharmD, BCOP

Associate Director of Pharmacy Clinical Services, Florida Cancer Specialists and Research Institute

Chinyere Eigege, PhD, LCSW-S
Chinyere Eigege, PhD, LCSW-S

Manager, Central Social Work Operations, McKesson Corporation

Josh Eaves
Josh Eaves

Chief Development and Strategy Officer, Florida Cancer Specialists & Research Institute

David Eagle, MD
David Eagle, MD

Chair of Legislative Affairs and Patient Advocacy, New York Cancer & Blood Specialists

Stephen “Fred” Divers, MD
Stephen “Fred” Divers, MD

Chief Medical Officer, American Oncology Network

Davey B. Daniel, MD
Davey B. Daniel, MD

Chief Medical Officer, OneOncology

Misty D. Chicchirichi, MSN, RN, CEMC
Misty D. Chicchirichi, MSN, RN, CEMC

Senior Director, Quality Programs, Shenandoah Oncology

Melody Chang, RPh, BCOP, MBA
Melody Chang, RPh, BCOP, MBA

Vice President of Pharmacy Operations, American Oncology Network

Paul Chadwick
Paul Chadwick

Chief Value and Procurement Officer, Florida Cancer Specialists & Research Institute

Sarah Hogue, PharmD
Sarah Hogue, PharmD

Director, Oncology Pharmacy Services, St. Luke's Cancer Institute

Sophia Humphreys, PharmD, MHA, BCBBS
Sophia Humphreys, PharmD, MHA, BCBBS

Director, System Pharmacy Formulary Management & Clinical Programs, Sutter Health

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Clinical Pharmacy Manager, Division of Hematologic Malignances and Cellular Therapeutics, University of Kansas Cancer Center

Dax Kurbegov, MD, FASCO
Dax Kurbegov, MD, FASCO

Senior Vice President, Sarah Cannon Cancer Network

Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd
Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd

Clinical Professor (retired), Keck School of Medicine of USC

Sindhuja Kadambi, MD, MS
Sindhuja Kadambi, MD, MS

Assistant Professor, University of Rochester Medical Center

David Jackman, MD
David Jackman, MD

Medical Director, Clinical Pathways and New Business Initiatives, Dana-Farber Cancer Institute

Maen Hussein, MD
Maen Hussein, MD

Medical Oncologist, Florida Cancer Specialists & Research Institute

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Clinical Pharmacy Manager, Division of Hematologic Malignances and Cellular Therapeutics, University of Kansas Cancer Center

Richard Lewis Martin III, MD, MPH
Richard Lewis Martin III, MD, MPH

Director, Health Equity and Community Engagement, Tennessee Oncology

Kiana Mehring, MBA
Kiana Mehring, MBA

Senior Director of Strategic Partnerships, Managed Care, Florida Cancer Specialists & Research Institute

Alex Morozov, MD, PhD
Alex Morozov, MD, PhD

Chief Medical Officer, Pi Health

Brian P. Mulherin, MD
Brian P. Mulherin, MD

Medical Director, American Oncology Network, Inc

Samyukta ``Sam`` Mullangi, MD, MBA
Samyukta ``Sam`` Mullangi, MD, MBA

Medical Director, Medical Oncologist Thyme Care, Tennessee Oncology

Chris O'Dell
Chris O'Dell

Senior Vice President, Market Solutions, Turquoise Health

Kathy Oubre, MS
Kathy Oubre, MS

Chief Executive Officer, Pontchartrain Cancer Center

Kathryn Paliotta, RN
Kathryn Paliotta, RN

Vice President, Patient Communications, New York Cancer & Blood Specialists

Anne Marie F. Rainey, MSN, RN, CHC, CPHQ
Anne Marie F. Rainey, MSN, RN, CHC, CPHQ

Director of Value-Based Care, American Oncology Network

Alti Rahman, MHA, MBA, CSSBB
Alti Rahman, MHA, MBA, CSSBB

Chief Strategy and Innovation Officer, American Oncology Network

Lisa Raff, PharmD, MSPharm, BCPS, BCOP
Lisa Raff, PharmD, MSPharm, BCPS, BCOP

Vice President of Pharmacy Services, OneOncology

Judi Payne-De Bock, BSN
Judi Payne-De Bock, BSN

Senior Director Clinical Services, US Oncology Network

Barry Russo, MBA
Barry Russo, MBA

Chief Executive Officer, The Center for Cancer and Blood Disorders

BrandiLee Sawyer
BrandiLee Sawyer

Patient Care Coordinator, First Ascent Biomedical

Alyssa Schatz, MSW
Alyssa Schatz, MSW

Vice President, Policy and Advocacy, National Comprehensive Cancer Network

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Assistant Professor, Mayo Clinic College of Medicine and Science

Bruce Wilson
Bruce Wilson

Vice President US Oncology Care & Access, AstraZeneca

Dana Weber, MSN, RN
Dana Weber, MSN, RN

Sr. Manager, Transformation & Quality, The US Oncology Network

Emily Touloukian, DO
Emily Touloukian, DO

President and CEO, Coastal Cancer Center

Ann Sweeney, MA, CCMP
Ann Sweeney, MA, CCMP

Senior Director Quality Programs & Process Improvement, Blue Ridge Cancer Care

Samuel Stolpe, PharmD, MPH
Samuel Stolpe, PharmD, MPH

Head of Healthcare Quality Strategy, Johnson & Johnson Innovative Medicine

Stuart Staggs, MSIE
Stuart Staggs, MSIE

Vice President, Transformation & Shared Services, US Oncology Network

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Clinical Pharmacy Manager, Division of Hematologic Malignances and Cellular Therapeutics, University of Kansas Cancer Center

ATTENDEES REPRESENT LEADING INSTITUTIONS IN VALUE-BASED ONCOLOGY CARE
  • Connecticut Oncology Association/DGH Consulting LLC
  • Oncology PA Solutions
  • McKesson/US Oncology
  • Evolent Health
  • oneoncology
  • Thrive Beyond Coaching
  • American Oncology Network
  • Colla Mental Health
  • Fedora Healthcare Solutions
  • Smirta
  • American Cancer Society
  • AONN+
  • managecare.ai
  • Celltrion
  • Peace Health Sacred Heart – Riverbend Hospital
  • erlanger health
  • erlanger
  • Compass Oncology
  • POHMS/Alliance Cancer
  • Blue Spark Technologies
  • Oncology Health Partners
  • Vanderbilt University Medical Center
  • Thyme Care
  • Tier1 Healthcare Advisors
  • McKesson
  • Tennessee Oncology
  • EXL Health
  • OneOncology
  • mskcc
  • Patient Discovery
  • Reimagine Care
  • Vanderbilt University Medical Center
  • Premier Oncology Hematology Management Society
WHAT YOUR COLLEAGUES ARE READING ON AJMC.COM
Explore the most sought-after PCOC coverage

Information and Integration Can Take Oncology Patients From Surviving to Thriving

In Primary Care–Oncology Collaboration, the Baton Goes Both Ways

Oncology Pharmacists in the Spotlight Amid Rising Drug Costs and Workforce Pressures

Trust and Transparency Key for Leveraging AI to Expand Access to Precision Oncology

Access Video Interviews from PCOC